1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,800 | 4,040 | 23.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.12. | M Stanley Elevates WUXI XDC TP to $34.8, Raises Earnings Forecasts | 1 | AASTOCKS | ||
| 21.11. | WUXI XDC (02268): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| 21.11. | WUXI XDC (02268): (1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND (2) CHANGE IN COMPOSITION OF BOARD COMMITTEES | 2 | HKEx | ||
| 25.10. | WUXI XDC (02268): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 25, 2024 | 2 | HKEx | ||
| 24.10. | Neues Speziallabel für Krebsstudien: Für eine klinische Krebsstudie nutzt WuXi XDC ein spezielles Lichtschutzlabel ... | 2 | packaging journal | ||
| 23.10. | WuXi XDC Taps Schreiner MediPharm for ADC Drug Label Solution | 6 | Contract Pharma | ||
| 09.10. | WUXI XDC (02268): FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, OCTOBER 25, 2024 | 1 | HKEx | ||
| WUXI XDC Aktie jetzt für 0€ handeln | |||||
| 09.10. | WUXI XDC (02268): NOTICE OF EXTRAORDINARY GENERAL MEETING | 2 | HKEx | ||
| 09.10. | WUXI XDC (02268): REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE ANTIBODIES MASTER SERVICES AGREEMENT AND NOTICE OF EXTRAORDINARY ... | 1 | HKEx | ||
| 04.10. | WUXI XDC (02268): CLOSURE OF REGISTER OF MEMBERS | - | HKEx | ||
| 30.09. | WUXI XDC (02268): GRANT OF RESTRICTED SHARES UNDER THE 2024 SHARE SCHEME | 1 | HKEx | ||
| 30.09. | WUXI XDC (02268): FURTHER DELAY IN DESPATCH OF CIRCULAR | 1 | HKEx | ||
| 26.09. | WUXI XDC (02268): INTERIM REPORT 2024 | 1 | HKEx | ||
| 16.09. | WUXI XDC (02268): DELAY IN DESPATCH OF CIRCULAR | - | HKEx | ||
| 26.08. | WUXI XDC (02268): REVISION OF ANNUAL CAPS FOR EXISTING CONTINUING CONNECTED TRANSACTIONS AGREEMENTS | 1 | HKEx | ||
| 20.08. | WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth | 319 | PR Newswire | Revenue surged by 67.6% YoY to RMB 1,665 million
Gross profit surged by 133.4% to RMB 535 million, with a gross profit margin of 32.1%, a 9.0 percentage points increase compared to 1H 2023.
Net profit... ► Artikel lesen | |
| 20.08. | WUXI XDC (02268): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 | 1 | HKEx | ||
| 29.07. | WUXI XDC (02268): NOTICE OF BOARD MEETING | 1 | HKEx | ||
| 12.07. | WUXI XDC (02268): GRANT OF RESTRICTED SHARES UNDER THE 2024 SHARE SCHEME | 1 | HKEx | ||
| 25.03. | WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones | 153 | PR Newswire | Revenue reached RMB 2,124 million, an increase of 114% compared with Year 2022
Adjusted net profit reached RMB 412 million, an increase of 112% compared with Year 2022
Total number of integrated... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
WUXI XDC CAYMAN INC gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 3,780 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WUXI XDC CAYMAN INC finden Sie auf Wallstreet Online.
